top of page
230721_상트네어-web_illust_pipeline.jpg

Pipeline

01_2x.png

PIPELINE

TIMELINE

Pipeline

Targets

Indication

HER2

CTN001

HER2-Low Breast Cancer

CD33

CTN008

AML

EGFR/c-Met

CTN005

NSCLC

GPC3

CTN002

HCC

FGFR3

CTN012

Bladder cancer

MUC16

CTN013

Ovarian cancer

EGFR/EGFRvIlI

CTN014

Glioblastoma

OX40

CTN010

Severe atopic dermatitis

2023

2024

CMC & IND Enabling Studies

Lead Discovery/Optimization

Preclinical Studies

Lead Discovery/Optimization

Preclinical Studies

Lead Discovery/Optimization

Preclinical Studies

Lead Discovery/Optimization

Preclinical Studies

Lead Discovery/Optimization

Preclinical Studies

Lead Discovery/Optimization

Preclinical Studies

Lead Discovery/Optimization

Preclinical Studies

bottom of page